CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park

Cancer Research and Treatment. 2018;50(4):1252-1259. Published online 2018 January 2 DOI: https://doi.org/10.4143/crt.2017.438

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park

Cancer Research and Treatment. 2018;50(4):1252-1259

Link1

Link2 Link3

A phase II study of TKI258 in patients with castration-resistant prostate cancer (KCSG-GU11-05)

Y.J. Choi, H.S. Kim, S.H. Park, B.S. Kim, K.H. Kim, H.J. Lee, H.S. Song, D.Y. Shin, H.Y. Lee, H.-G. Kim, K.H. Lee, J.-L. Lee, K.H. Park

Annals of Oncology. 2016;27:vi249

Link1 Link2 Link3

Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study

David O’Reilly

Clinical Genitourinary Cancer. 2019;17(5):e886-e887

Link1 Link2

Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer

Robert J. Amato, L. Michael Glode, Jeremy Podolnick, Robert Knight, David Crawford

Cancers. 2011;3(3):3449-3460

Link1

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

T M Beer, D C Smith, A Hussain, M Alonso, J Wang, M Giurescu, K Roth, Y Wang

British Journal of Cancer. 2012;107(5):808-813

Link1

Link2 Link3

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Kei Matsuoka, Gaku Arai, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh

The Prostate. 2011;72(8):834-845

Link1 Link2

Lenalidomide Monotherapy in Chemotherapy-Naive, Castration-Resistant Prostate Cancer Patients: Final Results of a Phase II Study

Chadi Nabhan, Anand Patel, Dana Villines, Kathy Tolzien, Susan K. Kelby, Timothy M. Lestingi

Clinical Genitourinary Cancer. 2014;12(1):27-32

Link1 Link2

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Rei Ohnishi, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh

BMC Cancer. 2013;13(1):

Link1

Link2 Link3

Phase II study of fulvestrant (faslodex®) in castration resistant prostate cancer

Manpreet K. Chadha, Umeer Ashraf, David Lawrence, Lili Tian, Ellis Levine, Carrie Silliman, Paul Escott, Valencia Payne, Donald L. Trump

The Prostate. 2008;68(13):1461-1466

Link1 Link2

Exploratory Study of [18F]fluciclovine PET/CT for Response Assessment to Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer

. 2021;

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.